Glass Lewis

14 articles about Glass Lewis

• Leading Independent Proxy Advisory Firms Recommend Conatus Pharmaceuticals Shareholders Vote in Favor of its Merger with Histogen and the Required Reverse Stock Split

  5/18/2020

  Conatus Pharmaceuticals Inc. announced that Institutional Shareholder Services Inc. and Glass Lewis, have recommended that Conatus stockholders vote “FOR” Conatus’ proposed merger with Histogen Inc. and “FOR” Conatus’ proposed reverse stock split, both of which are to be considered at Conatus’ upcoming special meeting of stockholders to be held on May 21, 2020.

• Leading Independent Proxy Advisors Recommend Aurinia Shareholders Vote the YELLOW Proxy Card FOR All of Aurinia’s Director Nominees

  6/19/2019

  ISS and Glass Lewis Recommend Aurinia Shareholders Not Support ILJIN’s Nominees

• Flex Pharma Announces that ISS and Glass Lewis Recommend Shareholders Vote “FOR” All Agenda Items relating to Flex’s Strategic Merger with Salarius Pharmaceuticals

  6/10/2019

  Flex Pharma, Inc. announced that Institutional Shareholder Services Inc. and Glass Lewis recommend that shareholders vote FOR all agenda items before or at Flex Pharma’s June 14 Special Shareholders Meeting.

• ISS and Glass Lewis recommend MedReleaf shareholders vote FOR arrangement with Aurora Cannabis

  7/6/2018

  Arrangement between MedReleaf and Aurora Cannabis Inc., whereby Aurora intends to acquire all of the issued and outstanding common shares of MedReleaf

• Glass Lewis Recommends Medivation’s Stockholders Support The Company’s Current Board

  6/24/2016

• Leading Independent Proxy Advisory Firm Glass Lewis Recommends Relmada Therapeutics Stockholders Vote The WHITE Proxy Card "FOR" Relmada's Director Nominees: Shreeram Agharkar And Maged Shenouda

  12/15/2015

• Glass Lewis Recommends Mylan Shareholders Vote For Perrigo Transaction Proposal

  8/12/2015

• Institutional Shareholder Services Inc. And Glass Lewis Recommend That Shareholders Of Mallinckrodt And Questcor Pharmaceuticals, Inc. (Headquarters) Vote FOR Mallinckrodt's Acquisition Of Questcor

  8/4/2014

• Transcept Pharmaceuticals, Inc. Announces That Glass Lewis Recommends "AGAINST" All Proposals Subject To A Vote At The December 19, 2013 Special Meeting Of Stockholders

  12/16/2013

• b>ISS and Glass Lewis Recommend Vote for All Digirad Corporation Nominees on the WHITE Proxy Card

  4/24/2013

• Alcon, Inc. Independent Director Committee Notes RiskMetrics's and Glass Lewis' Opposition to Election of Novartis Corporation’ Designees to Alcon’s Board of Directors

  8/2/2010

• Independent Proxy Advisory Firms RiskMetrics and Glass Lewis Recommend That ProMetic Life Sciences Inc.'s Shareholders Vote in Favour of Management Proposals at Upcoming Annual and Special Meeting

  4/27/2010

• RiskMetrics and Glass Lewis Support Nabi Biopharmaceuticals' Proposed NicVAX Option and License Agreement

  2/18/2010

• RiskMetrics and Glass Lewis Recommend CardioDynamics International Corporation Shareholders Vote FOR the Proposed Merger With SonoSite Inc.

  8/6/2009